Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Gastroparesis

• A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
• Different Doses of Naronapride vs. Placebo in Gastroparesis
• Evaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron
• Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis
• Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
• PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis
• Compassionate Use of Domperidone for Refractory Gastroparesis
• Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis
• Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes
• A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
• Pioglitazone for Idiopathic Gastroparesis
• Rifaximin in Patients With Diabetic Gastroparesis
• A Scintigraphy Study in Adults With Diabetic Gastroparesis
• Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
• A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis
• Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy of Nimacimab in Patients With Diabetic Gastroparesis
• The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms
• Diabetic Gastroparesis Study 05
• A Study of CNSA-001 in Women With Diabetic Gastroparesis
• Buspirone for Early Satiety and Symptoms of Gastroparesis
• A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
• Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02
• A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
• A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
• Docusate/Senna for the Treatment of Diabetic Gastroparesis
• A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
• Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants
• A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)
• Naloxegol for Opioid-Related Gastroparesis
• Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
• RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease
• Domperidone for Chronic Nausea and Vomiting
• Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders
• Prucalopride Versus Placebo in Gastroparesis
• Domperidone Expanded Access Program for Oncology Patients With Gastroparesis Who Have Failed Standard Therapy
• Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
• Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes
• Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
• Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)
• The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
• Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis
• Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
• Treatment Use of Domperidone for Gastroparesis
• A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis
• Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis
• Study of Promethazine for Treatment of Diabetic Gastroparesis
• Haloperidol vs Conventional Therapy for Gastroparesis
• Prucalopride Versus Placebo in Gastroparesis
• Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis
• Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis
• Sancuso® for Gastroparesis: An Open Label Study.
• Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study
• Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis
• Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis
• Domperidone in Treating Patients With Gastrointestinal Disorders
• Diabetic Gastroparesis Efficacy/Safety Study of TZP-102
• Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis
• A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
• A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying
• Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
• Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
• The Use of Domperidone for Gastroparesis
• Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis
• Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis
• FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers
• An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus
• An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options
• A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers
• Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis
• Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
• Impact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis.
• Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients
• Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers
• GSK962040 Drug-drug Interaction Study With Ketoconazole
• Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance
• Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus
• The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis
• The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis
• Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis
• Domperidone for Refractory Gastrointestinal Disorders
• The Effect of Oxytocin on the Gastric Emptying
• Nortriptyline for Idiopathic Gastroparesis
• Domperidone for Relief of Gastrointestinal Disorders
• Domperidone in Refractory Gastroparesis
• Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.
• Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis
• Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis
• A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040
• Domperidone for Gastroparesis in Solid Organ Transplantation
• Effects of Sitagliptin on Gastric Emptying in Healthy Subjects
• Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
• Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis
• Placebo Controlled Trial of Botulinum Toxin for Gastroparesis
• Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia
• A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis
• Safety and Effectiveness of an Investigational Agent (GM-611) in Patients With Diabetic Gastroparesis
• Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying